Information:
Error:
ID
33921
Description
Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif; ODM derived from: https://clinicaltrials.gov/show/NCT02377323
Link
https://clinicaltrials.gov/show/NCT02377323
Keywords
Versions (1)
- 1/7/19 1/7/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
January 7, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Sclerosis NCT02377323
Eligibility Multiple Sclerosis NCT02377323
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT02377323
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Clinically isolated syndrome | Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive
Item
patients with cis or definite ms (rrms or spms);
boolean
C2921627 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
C0751967 (UMLS CUI [3])
C0751965 (UMLS CUI [4])
C0026769 (UMLS CUI [2])
C0751967 (UMLS CUI [3])
C0751965 (UMLS CUI [4])
Clinic Visit
Item
patients seen at our clinic within the last 2 years;
boolean
C0008952 (UMLS CUI [1])
Patients Untreated | Rebif Low dose | Rebif High dose
Item
patients untreated, or treated with either low dose or high dose rebif for at least two years;
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0752980 (UMLS CUI [2,1])
C0445550 (UMLS CUI [2,2])
C0752980 (UMLS CUI [3,1])
C0444956 (UMLS CUI [3,2])
C0332155 (UMLS CUI [1,2])
C0752980 (UMLS CUI [2,1])
C0445550 (UMLS CUI [2,2])
C0752980 (UMLS CUI [3,1])
C0444956 (UMLS CUI [3,2])
Age
Item
patients between 18 to 60 years old at time of treatment initiation;
boolean
C0001779 (UMLS CUI [1])
EDSS
Item
edss ≤ 5.5 at treatment initiation;
boolean
C0451246 (UMLS CUI [1])
Able to read French language | Able to write French language
Item
patients able to read and write in french.
boolean
C0586740 (UMLS CUI [1,1])
C0376246 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
C0376246 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
Multiple Sclerosis, Primary Progressive
Item
patients diagnosed with primary progressive ms;
boolean
C0751964 (UMLS CUI [1])
Disease Modification Pharmaceutical Preparations | Exception Rebif
Item
patients treated with other dmd, other than rebif;
boolean
C0012634 (UMLS CUI [1,1])
C3840684 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0752980 (UMLS CUI [2,2])
C3840684 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0752980 (UMLS CUI [2,2])
Comorbidity Influence Research results
Item
co-existence of other diseases that could influence outcomes.
boolean
C0009488 (UMLS CUI [1,1])
C4054723 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C4054723 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])